Back to Journals » Biologics: Targets and Therapy » Volume 18 » default
Biologics: Targets and Therapy
- View all (599)
- Volume 20, 2026 (12)
- Volume 19, 2025 (56)
- Volume 18, 2024 (35)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 18, 2024
Lactobacillus Protects Against Chronic Suppurative Otitis Media via Modulating RFTN1/ Lipid Raft /TLR4-Mediated Inflammation
Liu Z, Zhang F, Jia F, Li S, Jiang C, Ruan B, Long R
Biologics: Targets and Therapy 2024, 18:453-468
Published Date: 27 December 2024
Mapping of Subjective Measurements in Traditional Chinese Medicine to Objective Clinical Endpoints in Western Medicine
Zhang Y, Chow SC
Biologics: Targets and Therapy 2024, 18:433-452
Published Date: 24 December 2024
Biophysical Analysis of Therapeutic Antibodies in the Early Development Pipeline
Willis LF, Kapur N, Radford SE, Brockwell DJ
Biologics: Targets and Therapy 2024, 18:413-432
Published Date: 21 December 2024
ACE Loss Drives Renal Cell Carcinoma Growth and Invasion by Modulating AKT-FOXO1
Yin L, Mao L, Yin R, Lv C, Shi X, Yue C, Chen Y, Lu C, Wu Z, Xu K, Cao W
Biologics: Targets and Therapy 2024, 18:397-412
Published Date: 19 December 2024
The Association Between the rs2200733 SNP and Atrial Fibrillation Among Arabs: A Study from Jordan
Al-Kasasbeh AH, Khabour OF, Almomani R, Ababneh M, Ibdah R, Jarrah MI, Rawashdeh SI, Seif AM
Biologics: Targets and Therapy 2024, 18:389-395
Published Date: 17 December 2024
Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
Pong A, Chow SS, Chow SC
Biologics: Targets and Therapy 2024, 18:377-387
Published Date: 6 December 2024
Cholinesterase Inhibitor Reveals Synergistic Potential for Neural Stem Cell-Based Therapy in the 5xFAD Mouse Model of Alzheimer’s Disease
Wu CC, Lee YK, Tsai JK, Su YT, Ho YC, Chu TH, Chen KT, Chang CL, Chen JS
Biologics: Targets and Therapy 2024, 18:363-375
Published Date: 3 December 2024
Short and Medium Chain Fatty Acids in a Cohort of Naïve Multiple Sclerosis Patients: Pre- and Post-Interferon Beta Treatment Assessment
Barcutean L, Farczadi L, Manescu IB, Imre S, Maier S, Balasa R
Biologics: Targets and Therapy 2024, 18:349-361
Published Date: 15 November 2024
Effectiveness and Persistence of Anti-TNFα Treatment in Patients with Rheumatoid Arthritis – A 7 Years Real-World Cohort Study
Santos-Moreno P, Rodríguez-Vargas GS, Rodríguez-Linares P, Ibatá L, Martínez S, Rodríguez-Florido F, Rojas-Villarraga A
Biologics: Targets and Therapy 2024, 18:339-347
Published Date: 15 November 2024
Expression Levels of lncRNA NEAT1, miRNA-21, and IL-17 in a Group of Egyptian Patients with Behçet’s Disease: Relation to Disease Manifestations and Activity
Hussein WH, Ramadan H, Labib S, Hegazy GA, Shaker OG, Yusuf SM, Hassanien MA, Haroon MM
Biologics: Targets and Therapy 2024, 18:327-337
Published Date: 12 November 2024
Feasibility and Tolerability of Anlotinib Plus PD-1 Inhibitors for Previously-Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
Wang HL, Zhou SX, Kuang J, Xiao S, Li M
Biologics: Targets and Therapy 2024, 18:313-326
Published Date: 5 November 2024
Non-Surgical Management of Recurrent Naso-Orbital Hemangiomas with Bevacizumab: A Case Report
Liu S, Zhao H, Shi L, Ji H
Biologics: Targets and Therapy 2024, 18:307-311
Published Date: 24 October 2024
Safety and Efficacy of Long-Term Tocilizumab in a Cohort of Patients with Giant Cell Arteritis: An Italian Monocentric Retrospective Study
Terribili R, Grazzini S, Conticini E, Falsetti P, Biasi G, Fabiani C, Cantarini L, Frediani B
Biologics: Targets and Therapy 2024, 18:297-305
Published Date: 3 October 2024
Exploring Anticancer Potential of Lactobacillus Strains: Insights into Cytotoxicity and Apoptotic Mechanisms on HCT 115 Cancer Cells
Wang L, Xu Z, Bains A, Ali N, Shang Z, Patil A, Patil S
Biologics: Targets and Therapy 2024, 18:285-295
Published Date: 1 October 2024
Silencing AREG Enhances Sensitivity to Irradiation by Suppressing the PI3K/AKT Signaling Pathway in Colorectal Cancer Cells
Zhang W, Zhang W, Tang C, Hu Y, Yi K, Xu X, Chen Z
Biologics: Targets and Therapy 2024, 18:273-284
Published Date: 28 September 2024
Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab
Patra AK, Nayak S, Moharana A, Ojha P, Das SK, Akhtar J, Giri B, Singh S
Biologics: Targets and Therapy 2024, 18:257-271
Published Date: 17 September 2024
Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy
Jenča A, Mills DK, Ghasemi H, Saberian E, Jenča A, Karimi Forood AM, Petrášová A, Jenčová J, Jabbari Velisdeh Z, Zare-Zardini H, Ebrahimifar M
Biologics: Targets and Therapy 2024, 18:229-255
Published Date: 10 September 2024
Aspergillus Species from the Sabkha Marsh: Potential Antimicrobial and Anticancer Agents Revealed Through Molecular and Pharmacological Analysis
Sajer BH, Alshehri WA, Alghamdi SS, Suliman RS, Albejad A, Hakmi H
Biologics: Targets and Therapy 2024, 18:207-228
Published Date: 6 August 2024
Investigating the Underlying Molecular Mechanisms of Yunke on Bone Metastases from Prostate Cancer
Liu S, Tian Z, Zhang T, Zhang J, Huo Y, Ma C
Biologics: Targets and Therapy 2024, 18:195-206
Published Date: 22 July 2024
STAT5B Suppresses Ferroptosis by Promoting DCAF13 Transcription to Regulate p53/xCT Pathway to Promote Mantle Cell Lymphoma Progression
Zhang WJ, Hu CL, Guo BL, Liang XP, Wang CY, Yang T
Biologics: Targets and Therapy 2024, 18:181-193
Published Date: 4 July 2024
Enzymatic Routes for Chiral Amine Synthesis: Protein Engineering and Process Optimization
Vikhrankar SS, Satbhai S, Kulkarni P, Ranbhor R, Ramakrishnan V, Kodgire P
Biologics: Targets and Therapy 2024, 18:165-179
Published Date: 25 June 2024
Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human-Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes [Response to Letter]
Zhou Y, Huang CLH, Zhang Y
Biologics: Targets and Therapy 2024, 18:163-164
Published Date: 25 June 2024
Osteoimmune Interaction and TH-1/TH-2 Ratio in Jawbone Marrow Defects: An Underestimated Association – Original Research
Lechner J, von Baehr V, Notter F, Schick F
Biologics: Targets and Therapy 2024, 18:147-161
Published Date: 6 June 2024
Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes [Letter]
Wulandari M, Prihatono A, Rusdi AJ
Biologics: Targets and Therapy 2024, 18:145-146
Published Date: 5 June 2024
Response to “Lncrna GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC” [Letter]
Mahdi C, Wulandari M, Prisusanti RD
Biologics: Targets and Therapy 2024, 18:143-144
Published Date: 5 June 2024
LncRNA GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC
Zhang J, You Q, Wang Y, Ji J
Biologics: Targets and Therapy 2024, 18:129-142
Published Date: 23 May 2024
Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes
Zhou Y, Zhou R, Huang W, Wang J, Jiang C, Li A, Huang CLH, Zhang Y
Biologics: Targets and Therapy 2024, 18:115-127
Published Date: 10 May 2024
Successful Fistula Closure After Treatment with Colostomy and Infliximab in a Patient with Ulcerative Colitis Complicated by Rectovaginal Fistula
Katsube S, Matsumoto S, Misawa M, Kakizawa N, Hashimoto R, Mizutani T, Matsumoto K, Yoshikawa S, Mashima H
Biologics: Targets and Therapy 2024, 18:107-113
Published Date: 6 May 2024
TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus
Fajar DR, Rostinawati T, Hamijoyo L, Sahiratmadja E, Amalia R, Barliana MI
Biologics: Targets and Therapy 2024, 18:95-106
Published Date: 3 May 2024
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
Soberanis Pina P, Lheureux S
Biologics: Targets and Therapy 2024, 18:79-93
Published Date: 21 March 2024
MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
Lin W, Yan Y, Huang Q, Zheng D
Biologics: Targets and Therapy 2024, 18:61-78
Published Date: 31 January 2024
Advances with Platelet-Rich Plasma for Bone Healing
Bacevich BM, Smith RDJ, Reihl AM, Mazzocca AD, Hutchinson ID
Biologics: Targets and Therapy 2024, 18:29-59
Published Date: 25 January 2024
Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing
Asmamaw Mengstie M, Teshome Azezew M, Asmamaw Dejenie T, Teshome AA, Tadele Admasu F, Behaile Teklemariam A, Tilahun Mulu A, Mekonnen Agidew M, Adugna DG, Geremew H, Abebe EC
Biologics: Targets and Therapy 2024, 18:21-28
Published Date: 18 January 2024
Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature
Zavala-Valencia AC, Velasco-Hidalgo L, Martínez-Avalos A, Castillejos-López M, Torres-Espíndola LM
Biologics: Targets and Therapy 2024, 18:7-19
Published Date: 16 January 2024
Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis
Kojima S, Matsumoto S, Koito Y, Miura T, Sekine M, Uehara T, Asano T, Yamaguchi Y, Mashima H
Biologics: Targets and Therapy 2024, 18:1-6
Published Date: 12 January 2024